A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...
Clinical Trials Arena on MSN
Gilead’s HIV single-pill combo meets primary endpoints in pivotal trial
Gilead has become a significant name in the HIV landscape after its twice-yearly PrEP treatment Yeztugo touted 99.9% efficacy ...
10don MSN
Early HIV drugs give immune system a brief reprieve before dysregulation returns, study finds
Researchers at Amsterdam UMC investigated whether this dysregulation can be prevented by starting HIV medication immediately ...
New HIV infections among gay and bisexual men in the United States have fallen over the past few years, in part due to earlier and more widespread use of effective antiretroviral therapy, according to ...
The two-drug regimen dolutegravir/lamivudine is as effective as the three-drug regimen dolutegravir plus tenofovir alafenamide/emtricitabine in treatment-naive people with HIV infection.
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
News-Medical.Net on MSN
Investigating the impact of starting HIV drugs within days of infection
Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at ...
Brian Zanoni, MD, MPH, discusses forecasts that suggest declining global HIV rates but persistent gaps in care and funding.
The Gauteng Department of Health has strengthened its STI prevention strategy through targeted screening, outreach, and HIV ...
At dawn in Mengo, the sound of sneakers slapping against tarmac has become more than a sign of celebration; it’s a symbol of ...
The pace of new HIV infections in the U.S. continued to slow in 2021, the Centers for Disease Control and Prevention said in a new annual report Tuesday, suggesting trends that had already begun to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results